Sandostatin for Control of GH, IGF-1, Gastrointestinal HormoneSandostatin LAR Information
Sandostatin LAR Octreotide IM Injection












Search
 
  Administering Sandostatin® LAR®  

With its slow-release pharmacokinetic profile compared to Sandostatin® Injection, Sandostatin® LAR® can be administered once a month instead of 3 times a day, which may lead to enhanced patient compliance. In addition, improvements such as a new pre-filled vehicle syringe and redesigned needle size make mixing and administering Sandostatin® LAR® easier than ever.

Click on the following links for more detailed information on administering Sandostatin® LAR®.

To review frequently asked questions and answers on administering Sandostatin® LAR®, click here.

 
 
Learn More
Novartis Core Labeling Text
FAQ